Tutorials
XKRX:226950 (Korea, South)  
OliX Pharmaceuticals Inc logo

OliX Pharmaceuticals Inc

₩ 23200.00 (-1.28%) Aug 12
P/E:
At Loss
P/B:
31.47
Market Cap:
₩ 317.91B ($ 244.10M)
Enterprise V:
₩ 313.96B ($ 241.06M)
Volume:
57.05K
Avg Vol (2M):
144.59K
Volume:
57.05K
Market Cap ₩:
317.91B
Market Cap $:
244.10M
PE Ratio:
At Loss
Avg Vol (2-Month):
144.59K
Enterprise Value ₩:
313.96B
Enterprise Value $:
241.06M
PB Ratio:
31.47
GF Score:
Year:
EMBED
To
10Y: -%
Above Low: +NaN%
Below High: NaN%
Alerts Website Sources Stock Report
Dataset
Financial Download Tutorials

Business Description

OliX Pharmaceuticals Inc
No. 1014 Gwanggyo Ace Tower 1, Daehak 4-ro, Yeongtong-gu, Gyeonggi, Suwon, KOR, 16226
Description
OliX Pharmaceuticals Inc is a clinical stage biotechnology company. It is engaged in developing RNA interference (RNAi) technology therapeutics for dermal, ophthalmic and pulmonary diseases. The company's pipeline products include OLX101, OLX201, OLX301, OLX102, and others.
Name Current Vs Industry Vs History
Cash-To-Debt 1.11
Equity-to-Asset 0.13
Debt-to-Equity 3.71
Debt-to-EBITDA -1.33
Piotroski F-Score 4/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score 0.21
Distress
Grey
Safe
Beneish M-Score -2.97
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC
Name Current Vs Industry Vs History
5-Day RSI 50.21
9-Day RSI 53.38
14-Day RSI 52.52
6-1 Month Momentum % -24.34
12-1 Month Momentum % -52.77

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 1.05
Quick Ratio 1.04
Cash Ratio 0.98
Days Sales Outstanding 4.45

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -1.8

Guru Trades

See Details
To
EMBED
SAVE

Insider Trades

See Details
To
EMBED
SAVE

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To
EMBED
SAVE
Dividend
To
EMBED
SAVE

Annualized Return %

Symbol 1 Week 1 Month 3 Months 6 Months YTD 1 Year 3 Years 5 Years 10 Years

Total Annual Return %

Symbol 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013

Executives

Valuation Box

Year:
EMBED

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil ₩) 5,007.167
EPS (TTM) (₩) -2224
Beta 1.35
Volatility % 37.08
14-Day RSI 52.52
14-Day ATR (₩) 1341.131735
20-Day SMA (₩) 22125
12-1 Month Momentum % -52.77
52-Week Range (₩) 19150 - 51000
Shares Outstanding (Mil) 13.7

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 4
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

OliX Pharmaceuticals Inc Filings

Document Form Filing Date
No Filing Data